Top Markets
#1 ADO Protocol ADO Protocol +194.61%
#2 Islamic Coin Islamic Coin +155.39%
#3 GoPlus Security GoPlus Security +46.09%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#6 TENDIES TENDIES +14.77%
#7 Wrapped NXM Wrapped NXM +14.19%
#8 Verus Coin Verus Coin +13.64%
#9 Tutorial Tutorial +12.97%
#10 SkyAI SkyAI +12.58%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB
Rank in Stocks #33127
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Share Price
$0.28211392
Market Cap
$8.30M
Change (1 day)
11.11%
Change (1 year)
17.21%
Country
AU
Trade Cambium Bio Limited (CMB)

Category

Healthcare
EPS for Cambium Bio Limited (CMB)
EPS as of 2026 TTM: 0
According to Cambium Bio Limited latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Cambium Bio Limited from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE